Clinical Trial Update: Trial of Hematopoietic Stem Cells in Acute Myocardial Infarction [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating hematopoietic stem cell therapy in patients with reperfused acute myocardial infarction. The current status of the trial …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Hematopoietic Stem Cell Therapy

Snippet

Sponsor: TECAM Group | Conditions: Reperfused Acute Myocardial Infarction | Phase 2 | Status: UNKNOWN